László Márk

642 total citations
52 papers, 193 citations indexed

About

László Márk is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, László Márk has authored 52 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 17 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Cancer Research. Recurrent topics in László Márk's work include Lipoproteins and Cardiovascular Health (32 papers), Cancer, Lipids, and Metabolism (17 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers). László Márk is often cited by papers focused on Lipoproteins and Cardiovascular Health (32 papers), Cancer, Lipids, and Metabolism (17 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers). László Márk collaborates with scholars based in Hungary, India and United Kingdom. László Márk's co-authors include György Paragh, István Reiber, Zoltán Kiss, György Paragh, István Karádi, Zsolt Abonyi‐Tóth, Peter P. Tóth, Sreenivasa Rao Kondapally Seshasai, Lajos Fodor and György Rokszin and has published in prestigious journals such as Atherosclerosis, Nutrition and Clinical Therapeutics.

In The Last Decade

László Márk

45 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
László Márk Hungary 9 95 65 49 38 26 52 193
Karl Richardson United States 6 149 1.6× 40 0.6× 55 1.1× 53 1.4× 13 0.5× 29 316
Kristian Bailey United Kingdom 8 150 1.6× 37 0.6× 88 1.8× 35 0.9× 37 1.4× 16 320
Matteo Landolfo Italy 10 83 0.9× 50 0.8× 110 2.2× 16 0.4× 20 0.8× 31 344
Pratik Rane United States 8 105 1.1× 48 0.7× 76 1.6× 64 1.7× 17 0.7× 18 275
Shang-Jyh Hwang Taiwan 6 69 0.7× 40 0.6× 34 0.7× 20 0.5× 9 0.3× 8 284
Noor Alicezah Mohd Kasim Malaysia 9 83 0.9× 32 0.5× 45 0.9× 15 0.4× 13 0.5× 38 174
Jeanne M. Dobrzynski United States 7 159 1.7× 100 1.5× 103 2.1× 81 2.1× 26 1.0× 14 354
Shahin Jaffer Canada 8 135 1.4× 66 1.0× 94 1.9× 68 1.8× 13 0.5× 11 253
Longina Kłosiewicz−Latoszek Poland 9 144 1.5× 78 1.2× 66 1.3× 23 0.6× 29 1.1× 57 301
Damiano Parretti Italy 10 72 0.8× 47 0.7× 138 2.8× 61 1.6× 24 0.9× 20 280

Countries citing papers authored by László Márk

Since Specialization
Citations

This map shows the geographic impact of László Márk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Márk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Márk more than expected).

Fields of papers citing papers by László Márk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by László Márk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Márk. The network helps show where László Márk may publish in the future.

Co-authorship network of co-authors of László Márk

This figure shows the co-authorship network connecting the top 25 collaborators of László Márk. A scholar is included among the top collaborators of László Márk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with László Márk. László Márk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Márk, László, István Reiber, György Rokszin, et al.. (2024). A Nation-Wide Evaluation of Suboptimal Lipid-Lowering Treatment Patterns Among Patients Undergoing Intervention for Acute Coronary Syndrome in Hungary. Journal of Clinical Medicine. 13(21). 6562–6562. 1 indexed citations
4.
Kiss, Zoltán, György Rokszin, Ibolya Fábián, et al.. (2023). Mortality on DOACs Versus on Vitamin K Antagonists in Atrial Fibrillation: Analysis of the Hungarian Health Insurance Fund Database. Clinical Therapeutics. 45(4). 333–346. 1 indexed citations
6.
Fülöp, Péter, et al.. (2016). Changes in triglyceride, HDL-C, and non-HDL-C levels in patients with acute coronary syndrome. Wiener klinische Wochenschrift. 128(23-24). 858–863. 7 indexed citations
7.
Márk, László, Antonio J. Vallejo‐Vaz, István Reiber, et al.. (2015). Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary. Atherosclerosis. 241(1). 62–68. 18 indexed citations
8.
Márk, László, et al.. (2015). Improvement in prehospital time in acute coronary syndrome between 1985 and 2013 in the south-eastern area of Hungary. Wiener klinische Wochenschrift. 127(5-6). 218–221. 2 indexed citations
9.
Kiss, Zoltán, László Nagy, István Reiber, et al.. (2013). Persistence with statin therapy in Hungary. Archives of Medical Science. 3(3). 409–417. 20 indexed citations
11.
Reiber, István, et al.. (2011). Egyre.,célratörobb" lipidterápiás szokásaink-A Magyar MULTI GAP 2010 eredményei. Orvosi Hetilap. 152(21). 822–827. 2 indexed citations
12.
Márk, László, et al.. (2011). An attempt to make lipid-lowering therapy more effective in Hungary. The results of MULTI GAP 2010 and the Plus Program. Archives of Medical Science. 5(5). 760–765. 9 indexed citations
13.
Márk, László, et al.. (2011). Complex lipid-lowering treatment options in patients with a history of acute coronary syndrome. Orvosi Hetilap. 152(8). 296–302. 1 indexed citations
14.
Márk, László, István Reiber, & György Paragh. (2009). A reziduális kardiovaszkuláris rizikó csökkentése: a fenofibrát múltja, jelene és jövője. University of Debrecen Electronic Archive (University of Debrecen). 1 indexed citations
15.
Márk, László, et al.. (2007). Effects of ezetimibe on lipids and lipoproteins in patients with hypercholesterolemia and different apolipoprotein E genotypes. Current Medical Research and Opinion. 23(7). 1541–1548. 2 indexed citations
16.
Márk, László & György Paragh. (2007). Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption. Orvosi Hetilap. 148(14). 627–632. 2 indexed citations
17.
Márk, László, et al.. (2006). Cytochrome P450 2C9 polymorphism and acenocoumarol therapy.. PubMed. 64(4). 397–402; discussion 403. 14 indexed citations
18.
19.
Márk, László, et al.. (2000). [The effects of statins on stroke and cardiovascular incidence in randomized, placebo-controlled trials with clinical endpoints].. PubMed. 141(27). 1501–5. 1 indexed citations
20.
Márk, László, et al.. (1994). [Unrecognised acute myocardial infarct in a nine-year autopsy material].. PubMed. 135(26). 1411–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026